Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
CNTX | US
-0.10
-3.86%
Healthcare
Biotechnology
30/06/2024
10/04/2026
2.49
2.58
2.67
2.47
Context Therapeutics Inc. a biopharmaceutical company develops products for the treatment of solid tumors in the United States. It develops CLDN6xCD3 bsAb an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia Pennsylvania.
View LessValue Stock (Price to Book < 3)
Strong Sharpe Ratio (> 1.2)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
57.9%1 month
94.7%3 months
93.5%6 months
85.9%-
-
1.49
-
-
1.60
-
-
-20.01M
186.75M
186.75M
-
-
-
-
-29.68
3.89
1.64
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
0.51
Range1M
1.17
Range3M
2.23
Rel. volume
0.65
Price X volume
1.29M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | VYGR | Biotechnology | 3.74 | 203.95M | -5.56% | 29.89 | 13.99% |
| BioLineRx Ltd | BLRX | Biotechnology | 2.29 | 200.90M | 0.44% | n/a | 223.55% |
| Lexeo Therapeutics Inc. Common Stock | LXEO | Biotechnology | 5.98 | 197.70M | -7.00% | n/a | 6.58% |
| MONOPAR THERAPEUTICS | MNPR | Biotechnology | 56.08 | 197.42M | -3.18% | n/a | 0.00% |
| Ovid Therapeutics Inc | OVID | Biotechnology | 2.75 | 195.17M | -4.51% | n/a | 18.40% |
| MediWound Ltd | MDWD | Biotechnology | 17.85 | 192.54M | 0.45% | n/a | 0.00% |
| Century Therapeutics Inc. Common Stock | IPSC | Biotechnology | 2.25 | 190.61M | -0.44% | n/a | 25.38% |
| Bolt Technology Corp | BOLT | Biotechnology | 4.91 | 187.88M | 8.87% | n/a | 22.00% |
| Coherus BioSciences Inc | CHRS | Biotechnology | 1.68 | 185.94M | 1.82% | n/a | -354.71% |
| Assembly Biosciences Inc | ASMB | Biotechnology | 28.42 | 180.34M | -4.79% | n/a | 5.03% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CPI Card Group Inc | PMTS | Building Products & Equipment | 17.43 | 194.48M | 2.29% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 10.06 | 161.53M | -1.08% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.925 | 100.30M | 2.42% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.62 | 91.55M | 1.81% | 9.09 | 39.79% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.78 | 73.76M | 1.38% | 14.48 | 7.10% |
| ILAG | ILAG | Building Products & Equipment | 3.55 | 64.11M | 0.00% | n/a | 5.48% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.76 | 17.91M | 6.72% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.08 | 15.78M | -6.90% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.601 | 11.61M | -7.68% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.34 | 3.42M | 3.08% | n/a | 17.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.60 | - | Expensive |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 1.49 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 93.46 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 186.75M | - | Emerging |